Huntington National Bank Regeneron Pharmaceuticals, Inc. Transaction History

Huntington National Bank

  • $13.5 Billion
  • Q3 2024

A detailed history of Huntington National Bank transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Huntington National Bank holds 605 shares of REGN stock, worth $424,619. This represents 0.0% of its overall portfolio holdings.

Number of Shares
605
Previous 572 5.77%
Holding current value
$424,619
Previous $601,000 5.82%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024
BUY
$1024.09 - $1201.76 $33,794 - $39,658
33 Added 5.77%
605 $636,000
Q2 2024

Aug 08, 2024
SELL
$883.2 - $1071.19 $70,656 - $85,695
-80 Reduced 12.27%
572 $601,000
Q1 2024

May 03, 2024
BUY
$902.69 - $993.35 $157,068 - $172,842
174 Added 36.4%
652 $627,000
Q4 2023

Feb 07, 2024
BUY
$775.18 - $881.7 $13,953 - $15,870
18 Added 3.91%
478 $419,000
Q3 2023

Nov 08, 2023
SELL
$692.45 - $844.37 $128,795 - $157,052
-186 Reduced 28.79%
460 $378,000
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $130,905 - $155,275
-187 Reduced 22.45%
646 $464,000
Q1 2023

May 10, 2023
SELL
$680.49 - $826.97 $108,878 - $132,315
-160 Reduced 16.11%
833 $684,000
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $57,882 - $62,843
-82 Reduced 7.63%
993 $716,000
Q3 2022

Nov 07, 2022
SELL
$573.97 - $724.32 $60,840 - $76,777
-106 Reduced 8.98%
1,075 $740,000
Q2 2022

Aug 09, 2022
SELL
$548.35 - $738.84 $232,500 - $313,268
-424 Reduced 26.42%
1,181 $698,000
Q1 2022

May 10, 2022
SELL
$595.12 - $698.43 $31,541 - $37,016
-53 Reduced 3.2%
1,605 $1.12 Million
Q4 2021

Jan 21, 2022
BUY
$543.48 - $670.97 $4,347 - $5,367
8 Added 0.48%
1,658 $1.05 Million
Q3 2021

Oct 28, 2021
BUY
$574.03 - $680.96 $45,922 - $54,476
80 Added 5.1%
1,650 $998,000
Q2 2021

Jul 30, 2021
BUY
$472.8 - $558.54 $337,106 - $398,239
713 Added 83.2%
1,570 $877,000
Q1 2021

Apr 12, 2021
BUY
$446.73 - $548.2 $30,377 - $37,277
68 Added 8.62%
857 $405,000
Q4 2020

Jan 11, 2021
BUY
$478.3 - $607.98 $35,872 - $45,598
75 Added 10.5%
789 $381,000
Q3 2020

Oct 30, 2020
BUY
$544.75 - $658.21 $135,098 - $163,236
248 Added 53.22%
714 $400,000
Q2 2020

Jul 30, 2020
SELL
$493.32 - $643.92 $22,692 - $29,620
-46 Reduced 8.98%
466 $291,000
Q1 2020

Apr 27, 2020
BUY
$336.18 - $494.43 $23,196 - $34,115
69 Added 15.58%
512 $250,000
Q4 2019

Jan 17, 2020
SELL
$274.13 - $376.51 $41,119 - $56,476
-150 Reduced 25.3%
443 $166,000
Q3 2019

Nov 01, 2019
SELL
$273.46 - $318.39 $196,891 - $229,240
-720 Reduced 54.84%
593 $164,000
Q2 2019

Jul 23, 2019
SELL
$299.6 - $414.82 $424,233 - $587,385
-1,416 Reduced 51.89%
1,313 $411,000
Q1 2019

Apr 09, 2019
SELL
$372.08 - $439.57 $336,360 - $397,371
-904 Reduced 24.88%
2,729 $1.12 Million
Q4 2018

Jan 28, 2019
SELL
$335.82 - $403.04 $434,551 - $521,533
-1,294 Reduced 26.26%
3,633 $1.36 Million
Q3 2018

Oct 18, 2018
SELL
$351.14 - $408.51 $1.04 Million - $1.21 Million
-2,959 Reduced 37.52%
4,927 $1.99 Million
Q2 2018

Jul 19, 2018
SELL
$284.6 - $344.99 $4.67 Million - $5.67 Million
-16,422 Reduced 67.56%
7,886 $2.72 Million
Q1 2018

Apr 30, 2018
BUY
$315.82 - $393.78 $7.64 Million - $9.53 Million
24,192 Added 20855.17%
24,308 $8.37 Million
Q4 2017

Feb 02, 2018
SELL
$358.63 - $469.95 $8,248 - $10,808
-23 Reduced 16.55%
116 $44,000
Q3 2017

Oct 24, 2017
BUY
$431.38 - $504.0 $59,961 - $70,056
139
139 $62,000

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Huntington National Bank Portfolio

Follow Huntington National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email